跳至主要内容
临床试验/IRCT201603109568N15
IRCT201603109568N15已完成未知

The effectiveness of the combined treatment with vaginal progesterone plus cervical pessary compared to vaginal progesterone monotherapy for the prevention of preterm birth: a randomized clinical trial.

Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences0 个研究点目标入组 144 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • 18-40 years of age; singleton gestation; 18-22 gestational weeks; cervical length of less than 25 millimeters by transvaginal ultrasound; no cervical dilation; no history of any medical illness.
  • Exclusion criteria: : any medical illness upon enrollment; having urogenital infection; major fetal abnormalities; painful regular uterine contractions; placenta previa; ruptured membranes; active vaginal bleeding; history of cone biopsy; refusing to provide informed consent to participate in the study.

排除标准

  • 未提供

研究者

发起方
Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences

相似试验

Vaginal progesterone plus cervical pessary for... | 临床试验